Literature DB >> 35918877

Water intake, thirst, and copeptin responses to two dehydrating stimuli in lean men and men with obesity.

Douglas C Chang1, Adela Penesova1, Joy C Bunt1, Emma J Stinson1, Stavros A Kavouras2, Marci E Gluck1, Ethan Paddock1, Mary Walter3, Paolo Piaggi1, Jonathan Krakoff1.   

Abstract

OBJECTIVE: Physiological systems responsible for water homeostasis and energy metabolism are interconnected. This study hypothesized altered responses to dehydration including thirst, ad libitum water intake, and copeptin in men with obesity.
METHODS: Forty-two men (22 lean and 20 with obesity) were stimulated by a 2-hour hypertonic saline infusion and a 24-hour water deprivation. In each dehydrating condition, thirst, ad libitum water intake after dehydration, and urinary and hormonal responses including copeptin were assessed.
RESULTS: After each dehydration condition, ad libitum water intake was similar between both groups (p > 0.05); however, those with obesity reported feeling less thirsty (p < 0.05) and had decreased copeptin response and higher urinary sodium concentrations when stressed (p < 0.05). Angiotensin II, aldosterone, atrial and brain natriuretic peptides, and apelin concentrations did not differ by adiposity group and did not explain the different thirst or copeptin responses in men with obesity. However, leptin was associated with copeptin response in lean individuals during the hypertonic saline infusion (p < 0.05), but the relationship was diminished in those with obesity.
CONCLUSIONS: Diminished thirst and copeptin responses are part of the obesity phenotype and may be influenced by leptin. Adiposity may impact pathways regulating thirst and vasopressin release, warranting further investigation.
© 2022 The Obesity Society (TOS). This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35918877      PMCID: PMC9420804          DOI: 10.1002/oby.23520

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   9.298


  32 in total

1.  Central effects of leptin on cardiovascular and neurohormonal responses in conscious rabbits.

Authors:  K Matsumura; I Abe; T Tsuchihashi; M Fujishima
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-05       Impact factor: 3.619

Review 2.  A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension.

Authors:  J B Byrd; R D Brook
Journal:  J Hum Hypertens       Date:  2013-05-23       Impact factor: 3.012

3.  Living with water stress: evolution of osmolyte systems.

Authors:  P H Yancey; M E Clark; S C Hand; R D Bowlus; G N Somero
Journal:  Science       Date:  1982-09-24       Impact factor: 47.728

Review 4.  Vasopressin: physiology, assessment and osmosensation.

Authors:  L Bankir; D G Bichet; N G Morgenthaler
Journal:  J Intern Med       Date:  2017-07-26       Impact factor: 8.989

5.  Rat brain natriuretic peptide (BNP) reduces water intake following dehydration.

Authors:  Y Uehara; H Shimizu; Y Shimomura; I Kobayashi; S Kobayashi
Journal:  Neuropeptides       Date:  1990-10       Impact factor: 3.286

6.  Impact of obesity on plasma natriuretic peptide levels.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Peter W F Wilson; Ramachandran S Vasan
Journal:  Circulation       Date:  2004-02-10       Impact factor: 29.690

7.  Effects of acute water load, hypertonic saline infusion, and furosemide administration on atrial natriuretic peptide and vasopressin release in humans.

Authors:  T Kimura; K Abe; K Ota; K Omata; M Shoji; K Kudo; K Matsui; M Inoue; M Yasujima; K Yoshinaga
Journal:  J Clin Endocrinol Metab       Date:  1986-05       Impact factor: 5.958

8.  Effect of atrial natriuretic peptide on thirst and arginine vasopressin release in humans.

Authors:  L M Burrell; H J Lambert; P H Baylis
Journal:  Am J Physiol       Date:  1991-03

9.  Effect of obesity and weight loss on arginine vasopressin response to metoclopramide and nicotine from cigarette smoking.

Authors:  P Chiodera; L Capretti; C Davoli; A Caiazza; L Bianconi; V Coiro
Journal:  Metabolism       Date:  1990-08       Impact factor: 8.694

Review 10.  Vasopressin and Copeptin in health and disease.

Authors:  Mirjam Christ-Crain
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.